Arvinas (ARVN) Other Non Operating Income (2017 - 2026)
Arvinas (ARVN) recorded quarterly Other Non Operating Income of -$100000.0 in Q1 2026, up 66.67% quarter-over-quarter from -$300000.0 in Q2 2025.
Arvinas (ARVN) Other Non Operating Income (2017 - 2026) Analysis & Trends
Arvinas' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$100000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income changed N/A year-over-year to -$100000.0; the TTM figure through Mar 2026 stood at -$400000.0 (up 86.21% YoY), while the FY2025 annual figure was -$400000.0, up 86.21% from the prior year.
- Other Non Operating Income was -$100000.0 for Q1 2026 at Arvinas, up from -$300000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $600000.0 in Q4 2022 to a low of -$2.6 million in Q3 2024.
- Historically, Other Non Operating Income has averaged -$390909.1 across 5 years, with a median of -$100000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income dropped 25.0% in 2022, then tumbled 1000.0% in 2023.
- A 5-year view of Other Non Operating Income shows it stood at $600000.0 in 2022, then tumbled by 116.67% to -$100000.0 in 2023, then slumped by 100.0% to -$200000.0 in 2024, then tumbled by 50.0% to -$300000.0 in 2025, then jumped by 66.67% to -$100000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$100000.0 (Q1 2026), -$300000.0 (Q2 2025), and -$200000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | -2.60 Mn |
| Jun 30, 2024 | -100,000.00 |
| Dec 31, 2023 | -100,000.00 |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 1.20 Mn |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 144,215.00 |
| Jun 30, 2020 | 307,743.00 |
| Mar 31, 2020 | 390,009.00 |
| Dec 31, 2019 | 595,443.00 |